Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older CAIV-T, Liquid Formulation
Brief Summary: The purpose of this study is to determine the efficacy, safety and tolerability of the liquid formulation of CAIV-T against culture confirmed influenza illness in adults aged 60 years and older. In addition this study aims to demonstrate superiority of CAIV-T when compared with placebo and the effect on economic resources.


Options:
A: Arm Label: split-virion, adjuvanted H1N1 vaccine of 7.5 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose | Arm Label: split-virion, adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 30 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose | Arm Label: whole-virion, adjuvanted H1N1 vaccine of 5 μg; Type: EXPERIMENTAL; Interventions: Biological: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose | Arm Label: whole-virion, adjuvanted H1N1 vaccine of 10 μg; Type: EXPERIMENTAL; Interventions: Biological: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose | Arm Label: Placebo control; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo control | Intervention Type: BIOLOGICAL; Name: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 7.5 μg | Intervention Type: BIOLOGICAL; Name: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 30 μg | Intervention Type: BIOLOGICAL; Name: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose; Assigned to Arm(s): whole-virion, adjuvanted H1N1 vaccine of 5 μg | Intervention Type: BIOLOGICAL; Name: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose; Assigned to Arm(s): whole-virion, adjuvanted H1N1 vaccine of 10 μg | Intervention Type: BIOLOGICAL; Name: placebo control; Assigned to Arm(s): Placebo control
B: Arm Label: Group 4: Placebo: Intramuscular; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Group 3: Placebo: Nasal; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Group 1: FluMist™; Type: EXPERIMENTAL; Interventions: Biological: Cold-adapted live attenuated influenza virus vaccine, trivalent | Arm Label: Group 2: Fluzone®/Fluvirin; Type: EXPERIMENTAL; Interventions: Biological: Trivalent inactivated influenza vaccine | Intervention Type: BIOLOGICAL; Name: Cold-adapted live attenuated influenza virus vaccine, trivalent; Assigned to Arm(s): Group 1: FluMist™ | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Group 4: Placebo: Intramuscular | Intervention Type: BIOLOGICAL; Name: Trivalent inactivated influenza vaccine; Assigned to Arm(s): Group 2: Fluzone®/Fluvirin | Intervention Type: BIOLOGICAL; Name: Trivalent inactivated influenza vaccine; Assigned to Arm(s): Group 2: Fluzone®/Fluvirin | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Group 3: Placebo: Nasal
C: Intervention Type: BIOLOGICAL; Name: CAIV-T; Assigned to Arm(s): N/A
D: Arm Label: split-virion, adjuvanted H1N1 vaccine of 7.5 μg; Type: EXPERIMENTAL; Interventions: Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 7.5 μg | Arm Label: split-virion, adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 15 μg | Arm Label: split-virion, adjuvanted H1N1 vaccine of 30 μg; Type: EXPERIMENTAL; Interventions: Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 30 μg | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: Experimental: split-virion, non-adjuvanted H1N1 vaccine of 15 μg | Arm Label: Placebo control; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo Comparator: Placebo control | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 30 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 30 μg; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 30 μg | Intervention Type: BIOLOGICAL; Name: Experimental: split-virion, adjuvanted H1N1 vaccine of 7.5 μg; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 7.5 μg | Intervention Type: BIOLOGICAL; Name: Experimental: split-virion, adjuvanted H1N1 vaccine of 15 μg; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: Experimental: split-virion, adjuvanted H1N1 vaccine of 30 μg; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 30 μg | Intervention Type: BIOLOGICAL; Name: Experimental: split-virion, non-adjuvanted H1N1 vaccine of 15 μg; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: Placebo Comparator: Placebo control; Assigned to Arm(s): Placebo control

Answer: C